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ORIGINAL ARTICLE
Prevalence of abnormal findings when adopting new
national and international Global Lung Function Initiative
reference values for spirometry in the Finnish general
population
Annette Kainu1*, Ari Lindqvist2 and Anssi R. A. Sovija¨rvi3
1HUCH Heart and Lung Center, Peijas Hospital, University of Helsinki and Helsinki University Hospital,
Helsinki, Finland; 2Research Unit of Pulmonary Diseases, University of Helsinki and Helsinki University
Hospital, Helsinki, Finland; 3Department of Clinical Physiology and Nuclear Medicine, University of Helsinki
and Helsinki University Hospital, Helsinki, Finland
Background: New Finnish (Kainu2015) and international Global Lung Function Initiative (GLI2012)
reference values for spirometry were recently published. The aim of this study is to compare the interpretative
consequences of adopting these new reference values with older, currently used Finnish reference values
(Viljanen1982) in the general population of native Finns.
Methods: Two Finnish general population samples including 1,328 adults (45% males) aged 2174 years were
evaluated. Airway obstruction was defined as a reduced ratio of forced expiratory volume in one second (FEV1)/
forced vital capacity (FVC), possible restrictive pattern as reduced FVC, and decreased ventilatory capacity as reduced
FEV1 below their respective 2.5th percentiles. The severity gradings of reduced lung function were also compared.
Results: Using the Kainu2015 reference values, the prevalence of airway obstruction in the population was 5.6%;
using GLI2012 it was 4.0% and with Viljanen1982 it was 13.0%. Possible restrictive pattern was found in 4.2% using
the Kainu2015 values, in 2.0% with GLI2012, and 7.9% with the Viljanen1982 values. The prevalence of decreased
ventilatory capacity was 6.8, 4.0, and 13.3% with the Kainu2015, GLI2012 and Viljanen1982 values, respectively.
Conclusions: The application of the GLI2012 reference values underestimates the prevalence of abnormal
spirometric findings in native Finns. The adoption of the Kainu2015 reference values reduces the prevalences
of airways obstruction, decreased ventilatory capacity, and restrictive impairment by approximately 50%.
Changing from the 2.5th percentile, the previously used lower limit of normal, to the 5th percentile
recommended by the American Thoracic Society/European Respiratory Society will not increase the
prevalence of abnormal findings in the implementation of spirometry reference values.
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S
pirometry is one of the most common clinical lung
function tests. Changes in interpretation criteria
will affect a large numbers of subjects and influence
the diagnostic sensitivity of pulmonary diseases such
as asthma and chronic obstructive pulmonary disease
(COPD) (1, 2). Lung function is mostly dependent on
sex, age, height, and ethnicity. Therefore, the selection of
appropriate reference values is essential. Different refer-
ence values produce widely differing predictions for
normality (3), a problem that has resulted in an effort to
produce global reference equations. The Global Lung
Function Inititiative (GLI) produced the first global
reference equations in 2012 (GLI2012) by collating refer-
ence data from different research groups and countries to
produce all-age reference values with continuous predic-
tions from childhood to old age (4, 5). Data from different
locations have been grouped according to mathematical
similarity with less focus on preconceived ethnic similarity.
Thus the largest group, ‘Caucasian’, is a very diverse
category, encompassing geographically varying locations
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and ethnic backgrounds from North and South America to
Europe, Australia, Asia, and Northern Africa (4).
There are yet very limited comparative data on the pra-
ctical implications of using the GLI2012 reference values
in different general populations. In Tunisia, Northern Africa,
the Caucasian prediction equations have been shown to
overestimate lung volumes, with mean z-scores for healthy
non-smokers of forced vital capacity (FVC) of 0.62 (SD
0.86) and of forced expiratory volume in one second (FEV1)
of 0.55 (SD 0.87) (6). In a primary care cohort from
the Netherlands, the grading of reduced lung function in
COPD was milder with the GLI2012 reference values
compared to the old European Coal and Steel Community
(ECSC) reference values, also due to the same prediction
difference (7). In Northern Sweden, the GLI2012 reference
values have been found to underestimate lung volumes
with an increasing age trend and also to overestimate
the prevalence of obstruction in females (8). In patient
samples from hospital laboratory spirometry databases in
Australia and Poland, it has been shown that the GLI2012
reference produces significantly higher predictions for
lung volumes compared to the previously used ECSC
reference values but a smaller difference when comparing
with the National Health and Nutrition Examination
Survey III reference data set in the United States (9, 10).
In some countries, different reference values are used in
different parts of the country, which can make interpre-
tation difficult when patients move from one area to another.
In Finland, the choice of reference values for native Finns
has been agreed upon and a uniform interpretation of test
results has been in practice for over 30 years (11). Currently,
two sets of reference values are used systematically for
clinical interpretation of spirometry for native Finns: one for
adults and the other for children (12, 13). The Viljanen1982
reference values for adults were formed with an occupa-
tional health cohort in late 1970s using the equipment and
methodology of that era. It has become necessary to
transition from these established, but outdated, reference
values to new values recorded with modern transducers and
that include elderly subjects. The implications of adopting
the recently published new reference values for native Finns
(Kainu2015) are not yet known (14).
New Finnish reference values have been developed
using similar modelling with the recently published
GLI2012 reference values (4, 14). In the healthy reference
population of native Finns, the GLI2012 reference equa-
tions underestimated FVC by 6.2% in males and 5.1% in
females with an age-dependent increasing trend (14).
In Brazil, the GLI2012 predictions were similarly found
to underestimate lung volumes in the reference values
population of white adults, especially in males, and in
older adults (15). In Japan, the secular trends in the
relationship between sitting and standing heights, that is,
the Cormic index, have been suggested to explain up to
50% of the age-specific variation in mean FEV1 and FVC
z-scores among healthy non-smokers and to justify the
continued need for national reference values (16, 17).
However, it is important to evaluate reference values in
random population samples to assess the validity of the
models and the implications of changing reference values.
The aim of this study was to compare the differences in
interpretation of spirometry results when applying the
new Finnish reference values by Kainu (14), the interna-
tional GLI2012 reference values (4), and the previously
used national reference equations by Viljanen (12) in a
random population sample of native Finns. The categories
of spirometric findings studied are airway obstruction,
possible restrictive pattern, and decreased ventilatory capa-
city, that is, decreased FEV1. The gradings of reduced
FEV1 were also compared.
Methods
We used the original population data from the FinEsS
study from two centres, Helsinki and Kemi (14, 18, 19). Data
from 633 subjects in Helsinki and 695 in Kemi with an
acceptable baseline spirometry were included in the present
study. The original studies were accepted by the Helsinki
University Central Hospital and La¨nsi-Pohja Hospital
boards of ethics, and all subjects gave informed consent.
Only data from native Finns and spirometry values before
an eventual bronchodilator test were used. The spirometry
procedure has been published in detail elsewhere (14). The
measurementswere undertakenusing the American Thoracic
Society (ATS) 1994 criteria (20). The methods are described
further in the Supplementary file. The spirometry variables
evaluated were FEV1, FVC, and the FEV1/FVC ratio.
The ATS/European Respiratory Society (ERS) Task
Force for spirometry (21) and the ATS 1994 criteria (20)
define the lower limit as the 5th percentile of predicted
values; this recommendation has been implemented in
many national reference values. In Finland, it has been
recommended to use the 2.5th percentile of the national
reference values suggested by Viljanen et al. to define an
abnormally reduced lung function in interpretation and
a grading of the decrease based on standard deviations
(12, 22). In the new international GLI2012 reference
values, the 2.5th percentile limit of z-score 1.96 was
suggested for screening and case finding in random
populations, whereas the 5th percentile limit of z-score
1.645 was suggested for clinical use to define abnorm-
ality when evaluating patients with known lung disease or
symptomatic individuals (4). Quanjer et al. evaluated the
clinical implications of changing reference values in a
tertiary care unit in Australia and Poland and suggested
the use of FEV1/FVCBLLN (lower limit of normal) and
FEV1 z-score B2 for airway obstruction and using
z-score 1.645 to define the LLN (10, 23).
In this study, we used the 2.5th percentile limit to define
LLN in all evaluated reference models and defined airway
obstruction (or airflow limitation) as FEV1/FVCBLLN
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and a possible restrictive pattern in spirometry as
FVCBLLN. Decreased ventilatory capacity was defined
as FEV1BLLN. For z-scores, the 2.5% limit was rounded
to 2 as proposed by Quanjer et al. (23). For comparison
of practical impact, the use of the z-score limit of 1.645
is also evaluated. In assessment of differences between
prediction models, a significant z-score difference of90.3
SD was used as proposed by Quanjer et al. (24).
For grading of reductions in lung function, the FEV1
relative to the reference standard was used following the
ATS/ERS standard for interpretation of spirometry (21).
By using the GLI2012 and Kainu2015 reference values,
a uniform categorisation was implemented using values
of the z-score between LLN and 2 for mild, 2 to
2.5 for moderate, 2.5 to 3 for moderately severe,
3 to 4 for severe, and below 4 for very severe reduc-
tion in FEV1 (23). For the Viljanen reference values, the
LLN is defined as the 2.5th percentile corresponding
to a z-score of 2. The published and currently used
categorisation of reduced FEV1 has defined values above
80% (2.5th percentile LLN) as normal and between 65
and 79% as mild reduction (22). To create a comparable
categorisation with the GLI2012 and Kainu2015 values,
in this study, we defined values above 80% as mild.
Further reductions in FEV1 were categorised based on
established division on standard deviations of the original
prediction model, with percent predicted limits of 7965%
considered moderate (23.5 SD), 6445% (3.55.5 SD)
moderately severe, 4425% severe (5.57.5 SD), and below
25% (B7.5 SD) very severe reduction in FEV1 (22).
The predicted values, LLN, z-score, and percentiles of
FEV1, FVC, and FEV1/FVC for each study participant
according to the GLI2012 and Kainu2015 reference equa-
tions were calculated with the statistical program R (version
2.15.1, www.cran.r-project.org). For GLI2012 values,
the macro provided by the GLI (www.ers-education.org/
guidelines/global-lung-function-initiative/tools/r-macro.aspx)
was used. All other statistical analyses were conducted
using the statistical program SPSS (IBM SPSS Statistics
for Macintosh, Version 22.0. Armonk, NY: IBM Corp.).
Correspondingly, predicted values and percentiles accord-
ing to the Viljanen1982 reference equations were calcu-
lated for all subjects, but since the model is valid only for
adults 1865 years, the range of extrapolated values are
indicated in tables and graphs. The kappa statistic was
used to evaluate the level of agreement between different
categorisations between the evaluated reference standards
(25). The chi-square test was used for categorical compar-
isons. The Student’s t-test for paired samples was used
to test statistical significance between continuous vari-
ables of the predicted values for FVC, FEV1, and FEV1/
FVC with Viljanen1982, GLI2012, and Kainu2015. A
p-value of 0.05 was chosen for statistical significance for
all analyses.
Results
The population sample consisted of 597 (45.0%) males
and 731 (55.0%) females. The mean age was 48.8 (SD
13.2) years in males and 48.2 (SD 12.9) years in females
with a range of 2174 years in both genders. The mean
BMI was 26.1 (SD 4.5) with a range of 16.953.3 kg/m2.
The mean height was 176.5 (SD 6.6) cm and 163.0 (SD
6.1) cm for males and females, respectively. A summary of
measured spirometric data and predicted values for the
entire population sample stratified by sex are shown in
Table 1.
The difference in population distribution of z-scores of
the Kainu2015 and GLI2012 reference values by age
category is shown in Fig. 1. The GLI2012 produced lower
predicted lung volumes than the Kainu2015 reference
values and thus the FVC and FEV1 z-scores are slightly
Table 1. Summary of measured spirometric data and predicted values by Kainu2015 (14), GLI2012 (4), and Viljanen1982 (12) in
a general population sample of native Finns*
Measured data Mean predicted value Measured value% predicted mean (SD)
Mean (SD) Range Kainu2015 GLI2012 Viljanen1982 Kainu2015 GLI2012 Viljanen1982
FVC (L)
Male 4.89 (0.95) 2.188.03 5.17§ 4.90§ 5.07§ 94.1 (12.7) 99.7 (12.9) 96.2 (12.6)
Female 3.49 (0.63) 1.685.39 3.65§ 3.48§ 3.59§ 95.6 (11.8) 100.5 (12.3) 97.7 (12.3)
FEV1 (L)
Male 3.79 (0.86) 1.026.15 4.03§ 3.89§ 4.12§ 93.6 (15.5) 97.1 (15.8) 91.5 (15.2)
Female 2.78 (0.56) 0.994.50 2.91§ 2.82§ 2.96§ 95.6 (12.6) 98.9 (13.0) 94.3 (12.6)
FEV1/FVC (%)
Male 77.2 (8.3) 34.898.4 77.9§ 79.5§ 81.3§ 99.0 (10.0) 97.0 (9.9) 95.0 (10.0)
Female 79.6 (6.5) 44.798.6 79.4§ 81.3§ 82.4§ 100.2 (7.5) 97.9 (7.4) 96.7 (7.3)
*Males, n597; females, n731; §p-value for paired t-test between predicted values with Viljanen1982 and Kainu 2015, Viljanen1982
and GLI2012 and Kainu2015 and GLI2012B0.001. FEV1forced expiratory volume in one second; FVCforced vital capacity;
GLIGlobal Lung Function Initiative.
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higher on average, especially in the older age groups.
When evaluating the FEV1/FVC ratio, all subjects
who showed normal values when assessed using the
Kainu2015 reference value (z-score 2) were also nor-
mal when assessed with the GLI2012 values. Compared
to the currently used Viljanen1982 reference values, both
the GLI2012 and Kainu2015 prediction models resulted
in fewer subjects with values categorised as abnormal, as
shown in Table 2.
The prevalence of obstruction, decreased ventilatory
capacity, and possible restrictive pattern using the evalua-
ted reference equations in age groups are illustrated in
Fig. 2. The Viljanen1982 values are valid only up to 65 years
and thus prevalences for each reference standard are also
reported separately for the age group of 2165 years in
Table 2, and the extrapolated range is shown as dotted
lines in Fig. 2.
In the complete study sample, 4.0, 5.6, and 13.0% of
subjects were classified as obstructed in baseline spiro-
metry with the GLI2012, Kainu2015, and Viljanen1982
reference values, respectively. Decreased ventilatory capa-
city was found in 4.0% of subjects with GLI2012, 6.9%
with Kainu2015, and 13.3% with the Viljanen1982 refer-
ence values. Significantly more subjects (7.9%) were
classified as having a possible restrictive pattern when
using the Viljanen1982 reference values compared to
4.2% with the Kainu2015 and 2.0% with the GLI2012
values. In contrast, 0.8, 1.6, and 2.5% of subjects had
only reduced FEV1 without reduced FEV1/FVC or FVC
with the GLI2012, Kainu2015, and Viljanen1982 refer-
ence values, respectively.
In all evaluated reference equations, the prevalence
of both obstruction and possible restrictive pattern of
spirometry was more prevalent in males. With the
Viljanen1982 reference values, the prevalence of possible
spirometric restrictive pattern showed a significantly
increasing trend with age in males. However, young
females below 30 years of age also had a prevalence of
–1,2
–1,0
–0,8
–0,6
–0,4
–0,2
0,0
0,2
0,4
0,6
20 30 40 50 60 70
di
ffe
re
nc
e 
in
 F
VC
z–
sc
o
re
di
ffe
re
nc
e 
in
 F
EV
1/
FV
C
z–
sc
o
re
Age, years
20 30 40 50 60 70
Age, years 20
2,0
–4,0
–3,0
–2,0
–1,0
0,0
1,0
30 40 50 60 70
Age, years
a)
–1,2
–1,0
–0,8
–0,6
–0,4
–0,2
0,0
0,2
0,4
0,6
di
ffe
re
nc
e 
in
 F
EV
1
z–
sc
o
re
b) c)
male n=597
female n=731
Fig. 1. Difference between Kainu2015 (14) and GLI2012 (4) z-scores in a random general population sample of native Finns for
(a) forced vital capacity (FVC), (b) forced expiratory volume in one second (FEV1), and (c) the FEV1/FVC ratio. Significant
difference limits of 90.3 SD as proposed by Quanjer et al. (24) are shown as dashed horizontal lines.
Table 2. Prevalence of obstruction (FEV1/FVCBLLN) and possible restrictive pattern (FVCBLLN) with both 2.5th and 5th
percentile limits for Kainu2015 (14) and GLI2012 (4) reference values and the established 2.5th percentile LLN for Viljanen1982
(12) stratified by sex and applicable age category
Obstruction
(FEV1/FVCBLLN)
Possible restrictive pattern
(FVCBLLN)
Decreased ventilatory capacity
(FEV1BLLN)
Reference value LLN Age category Male (%) Female (%) All (%) Male (%) Female (%) All (%) Male (%) Female (%) All (%)
Kainu2015 2.5% All 7.4* 4.2* 5.6* 5.2* 3.4* 4.2* 8.0* 5.7* 6.8*
2165 years 5.9*§ 4.1*§ 4.9*§ 4.3*§ 2.9*§ 3.5*§ 6.6*§ 5.0*§ 5.7*§
5.0% All 9.7* 7.3* 8.4* 9.4* 7.1* 8.1* 12.6* 8.9* 10.5*
2165 years 8.2* 7.5* 7.8* 7.8* 5.6* 6.6* 10.5* 8.1* 9.2*
GLI2012 2.5% All 6.0* 2.3* 4.0* 3.2* 1.0* 2.0* 5.5* 2.7* 4.0*
2165 years 5.3*$ 2.1*$ 3.5*$ 2.7*$ 0.8*$ 1.6*$ 4.5*$ 2.7*$ 3.5*$
5.0% All 9.0* 4.5* 6.6* 5.0* 3.4* 4.1* 9.0* 5.6* 7.2*
2165 years 7.8* 4.4* 5.9* 4.1* 3.1* 3.5* 7.4* 5.2* 6.2*
Viljanen1982 2.5% 2165 years 11.5§$ 10.2§$ 10.8§$ 7.6§$ 6.3§$ 6.9§$ 13.9§$ 9.2§$ 11.2§$
*Kainu2015 versus GLI2012 pB0.001; §Kainu2015 versus Viljanen1982 pB0.001; $GLI2012 versus Viljanen1982 pB0.001. LLNlower limit
of normal. The Viljanen1982 reference values provide predictions for adults 1865 years of age (12). Males, n597; females, n731; in the
age category 2165 years: males n512, females n655; 2.5%2.5th percentile; 5.0%5th percentile. For the Kainu2015 and GLI2012
reference values the LLN for 2.5th percentile is z-score B2 and the LLN for 5th percentile is z-score B1.645. For the Viljanen1982
reference values the 2.5th percentile is defined as FEV1/FVCB88% predicted, FVCB80% predicted, and FEV1B80% predicted.
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up to 7.9%, compared to none (0.0%) with GLI2012 and
1.9% with the Kainu2015 values (pB0.001) (Fig. 2).
The grading of reduced lung function with FEV1 by
using z-scores and the modified grading for interpreta-
tion of the Viljanen1982 reference value (2) are shown in
Fig. 3. The GLI2012 values produced systematically
lower lung volume values and thus also lower rates of
reduced lung volumes. The prevalence of moderate
reduction in lung function was more common in the
Viljanen1982 reference values: up to 12.4% of males had
moderately reduced FEV1, compared to 4.5% with the
Kainu2015 values and 2.5% with the GLI2012 values.
For grading of the levels of reduced lung function with
FEV1, the kappa statistic of agreement was 0.513 for
Viljanen1982 and 0.587 for GLI2012, compared to the
Kainu2015 predictions.
Overall the evaluated reference equations provided
very good to fair agreement between categorisations
in lung function abnormalities, with the kappa values
showing the best agreement between the Kainu2015 and
GLI2012 reference values at 0.86 (5th percentile limit) for
FEV1/FVC and 0.73 for FEV1BLLN. On all evaluated
models shown in Table 3, males had better levels of
agreement between the different models, with the excep-
tion of reduced FEV1, where females had a better level
of agreement between the Kainu2015 and Viljanen1982
reference values of the kappa value: 0.72 in females,
compared to 0.59 in males.
Discussion
Both the international GLI2012 reference values and the
new Finnish reference values (4, 14) produce lower pre-
valences of both airflow limitation and possible restrictive
pattern and less milder degrees of decreased ventilatory
capacity than the previously used Finnish national
reference values proposed by Viljanen. There is no golden
standard for the true prevalence of reduced lung function
in the general population, which makes evaluation of the
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Fig. 2. Prevalence of reduced FVC (a and b), FEV1 (c and d), and FEV1/FVC ratio (e and f) in different age categories stratified
by sex using the GLI2012 (4), Kainu2015 (14), and Viljanen1982 (12) reference values. For the GLI2012 and Kainu2015
reference values, the 2.5th percentile limit of z-score B2 and 5th percentile limit of z-score B1.645 are shown. For the
Viljanen1982 reference values, the lower limit of normal (LLN) was defined as 2.5th percentile. The Viljanen1982 reference
equations apply for adults 1865 years of age, but are currently used in clinical practice also for the elderly. Extrapolated values
are indicated with the black dashed line.
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representativeness of reference values difficult. Tradition-
ally, reference values are evaluated in samples of healthy
non-smoking subjects, but with this approach various
selection biases can significantly affect results. Amongst
healthy non-smoking subjects, reference values should
produce estimates equivalent to the LLN chosen and, in
general, the prevalence would be expected to be higher in
the general population.
Using the 2.5th percentile, the LLN definition of the
Viljanen1982 values, the prevalence of airflow limitation
of 13.0%, possible spirometric restrictive pattern of 7.9%,
and decreased ventilatory capacity of 13.3% would seem
to be very high for the general population. The GLI2012
values produced lower estimates of lung volumes than the
Kainu2015 or Viljanen1982 values, with a greater differ-
ence especially in the older age categories. Using the
GLI2012 equations, 4.0% of the people in the general
Finnish population showed airway obstruction, 2.0%
possible restrictive pattern, and 4.0% decreased ventila-
tory capacity, prevalences that appear to be too low given
the definition of the 2.5th percentile limit for the LLN.
In particular, the GLI2012 predicted values for females
produced only 2.3% prevalence for obstruction and 1.0%
for possible restrictive pattern. The GLI2012 equations
failed to find 32% of cases of obstruction and 55% of
cases of possible spirometric restrictive pattern compared
to the new Finnish values by Kainu. Thus, the findings
from our random population sample are in line with the
findings of the study analysing the reference values in
healthy non-smokers, which found that the GLI2012
equations underestimated lung volumes in healthy Finnish
adults by approximately 5% (14).
The new national reference values by Kainu et al.
reduced the estimates of both obstructive and restrictive
9,9 %
2,5 %
0,8 %
0,0 %
3,8 %
1,3 %
1,4 %
0,4 %
2,0 %
0,7 %
1,3 %
0,1 %
0 % 2 % 4 % 6 % 8 % 10 % 12 %
moderate
moderately severe
severe
very severe
moderate
moderately severe
severe
very severe
moderate
moderately severe
severe
very severe
G
LI
20
12
Ka
in
u2
01
5
Vi
lja
ne
n1
98
2
Fig. 3. Prevalence of degrees of reduction in FEV1 in the general population using the GLI2012 (4), Kainu2015 (14), and
Viljanen1982 (12) reference values. Reductions in the GLI2012 and Kainu2015 reference values graded according to Quanjer
et al. (23). Reductions in the Viljanen reference values graded according to Halttunen and Sovija¨rvi (22).
Table 3. Levels of agreement for obstruction (FEV1/FVCBLLN), possible restrictive pattern (FVCBLLN), and decreased
ventilatory capacity (FEV1BLLN) comparing each of the three reference equations with each other
Kappa statistic for agreement
FEV1/FVCBLLN FVCBLLN FEV1BLLN
LLN (%) Male Female All Male Female All Male Female All
Kainu2015 (14) vs. GLI2012 (4) 5 0.94 0.75 0.86 0.68 0.63 0.66 0.82 0.76 0.79
Kainu2015 (14) vs. GLI2012 (4) 2.5 0.89 0.70 0.82 0.75 0.43 0.62 0.80 0.63 0.73
Viljanen1982 (12) vs. GLI2012 (4) 2.5 0.53 0.32 0.44 0.48 0.24 0.38 0.43 0.41 0.43
Kainu2015 (14) vs. Viljanen1982 (12) 2.5 0.61 0.52 0.57 0.69 0.58 0.64 0.59 0.72 0.65
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findings by 50% compared to the currently used
Viljanen1982 values. Prevalences of 5.6% for airway
obstruction, 4.2% for possible restrictive pattern, and
6.9% for decreased ventilatory capacity would seem to be
in line with the expected level of prevalence in the general
population. Extrapolation of the equations by Viljanen to
ages over 65 years, beyond the actual measurements of the
original data set, increased the rate of misclassifications.
Limiting the comparison of the Viljanen1982 values to
the age category 2165 years, as shown in Table 2, still
results in approximately 100% larger prevalence estimates
of both obstruction and possible restrictive pattern
compared to the comparable 2.5th percentile LLN of
the Kainu2015 values. The prevalence of borderline obs-
truction and possible spirometric restrictive pattern by
the Viljanen1982 equations was higher also in younger
age categories, particularly in males as shown in Fig. 2.
When interpreting the individual results in clinic, accu-
rate estimates of normal values and LLN should be used.
In Finland, the Viljanen1982 values used the 2.5th per-
centile to define the LLN. The change to using the 5th
percentile LLN as recommended both by the ATS/ERS
Task Force, in the previous ATS 1994 standard, and by
the GLI2012 document for symptomatic subjects (4, 20, 21)
will potentially result in greater numbers of healthy indi-
viduals being labelled as having pathological values.
However, the present study demonstrates that the new
national reference values with 5th percentile LLN pro-
duce still slightly lower levels of abnormal findings as
currently found with the Viljanen1982 values (Table 2).
The difference with GLI2012 results from older females
in whom the GLI2012 values underestimate lung volumes
and to a lesser degree also obstruction. It have been sug-
gested that this is caused by secular trends in height and
the Cormic index, as recently demonstrated in Japan (17).
In addition, among healthy non-smokers in Northern
Sweden and Brazil, the GLI2012 predictions have been
found to underestimate lung volumes in a similarly age-
dependent way (8, 15).
In the study of GLI2012 reference values, FEV1/FVC
was found to be the least dependent on ethnicity (4). Our
findings are in line with these findings, with the prevalence
of reduced FEV1/FVC being closer in the new Finnish
and the GLI2012 reference values, in both evaluated
LLN criteria, than the lung volumes. However, using the
GLI2012 reference, the prevalence of obstruction was
lower than expected among females, which contrasts with
the findings in Sweden, where the GLI2012 reference
values were found to overestimate the prevalence of obs-
truction in healthy, female non-smokers (8).
Because the predicted FEV1 with the GLI2012 and
Kainu2015 equations were smaller than those predicted
by the Viljanen1982 equations in the 1274-year-old
population samples studied, the prevalence of mild to
moderately decreased ventilatory capacity was system-
atically highest with the Viljanen1982 equations. Given
the 2.5th percentile LLN and the corresponding cate-
gorisation of values below this threshold as moderately
reduced, the greatest difference was seen in the moder-
ately decreased ventilatory capacity, which was found in
9.9% with the Viljanen1982 values, in 3.8% with the
Kainu2015 values, and in 2.0% with the GLI2012 values.
This difference between reference standards disappeared
in the severely decreased ventilatory capacity; thus the
greatest differences are in the borderline category. The
large differences in the milder categories have a large im-
pact on clinical assessment, since cases previously classi-
fied as mild reductions with the Viljanen values will be
classified as normal when using the new Kainu values;
large differences in the prevalence estimates of common
lung conditions will result. Our findings are in line with
those from Sluga et al. reporting milder gradings of
severity of obstruction in primary care when changing
from the ECSC or Swanney et al. equations to the
GLI2012 reference values in the Netherlands (7).
This study represents a random general population
from two diverse locations in Finland: urban Helsinki
and the rural Kemi region. A non-responder study was
conducted in Kemi, which found the responders to be
representative of the general population despite younger
male smokers being less likely to attend (26). The study
participants were found to correspond well to the age and
sex distribution of the population at the time and the
smoking prevalences to other studies from the same time
period (27). The study measurements were undertaken
at a research laboratory with quality control protocols
tighter than usually available for epidemiological studies.
Anthropometric height and weight data were measured
by the research nurses, but unfortunately no sitting height
or Cormic index was recorded, which limits analyses
regarding the explanatory role of relative height. From
both centres, Helsinki and Kemi, 403 of the 1,328 studied
subjects were found to be healthy and non-smoking and
were included in the dataset, from which new reference
value models were derived, which can be seen as a limi-
tation of this study. The total sample size in the reference
values study was 1,000 adults, also including two other
centres, Kuopio and Tampere (14). Evaluation of refer-
ence values in selected healthy non-smoking populations
is inherently affected by the chosen selection criteria  the
level of exposures, symptoms, or other diseases permitted.
In order to assess the applicability of reference values in
the general population, a random population sample is
most representative aiming for the least selection biases.
This study aimed at evaluating the practical implications
of change in the reference values used and the level of
LLN from the 2.5th percentile to the 5th percentile
at the population level. Further study on non-related
population samples is needed to verify our findings.
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The age- and sex-related difference in lung volumes
found here warrants further study at the population level
into explanatory factors that need to be taken into con-
sideration when interpreting lung function at the indivi-
dual level. The Cormic index has rarely been included in
measurements of lung function but to validate the links
from other data suggesting secular and mostly non-linear
trends between age and lung volumes, new research into
this and possible other explanatory factors is needed to
better understand variations in what should be consid-
ered normal at the population and individual levels.
There are great benefits in developing joint reference
standards for lung function testing. However, recent
research like ours has found the GLI2012 to poorly
represent evaluated populations. This is not surprising
given the wide range of populations joined for combined
reference values. For clinical practice, national reference
values are needed until additional factors, like the Cormic
index, are found that could better explain the variation
found between populations. In Finland, national refer-
ence values have been used uniformly in all laboratories
with national recommendations published regularly, which
has limited interpretative differences within the country.
Since new Finnish reference values have been developed
with mathematical modelling similar to the GLI2012
model, we find that the grading of reduced lung function
proposed by Quanjer et al. can be used with both
reference models (23). New Finnish reference values are
suggested for use for adult native Finns, with GLI2012
to be used for all other ethnicities. Use of the ECSC
reference values should be discontinued. Further research
into incorporating different populations into separate
GLI models is needed.
Conclusions
In this study, we showed lower prevalences of a possi-
ble restrictive pattern (reduced FVC), airflow limitation
(reduced FEV1/FVC ratio), and decreased ventilatory
capacity (reduced FEV1) in two random Finnish general
population samples when using the international GLI2012
values compared to the new Kainu2015 values and the old
Viljanen1982 national values. The application of the
GLI2012 reference values for native Finns resulted in
lower-than-expected prevalence estimates, especially in
the category of possible restrictive patterns. The adoption
of the new Kainu2015 reference values for native Finns
instead of the old Viljanen1982 values will markedly
reduce the prevalence of obstruction, possible restrictive
pattern, and decreased ventilatory capacity in the general
population, by up to 50%, mostly from the borderline
and milder categories. The study compared fitting of the
three reference equations into general population samples
consisting of native 2174-year-old Finns. The results
favour implementation of the Kainu2015 values, both for
clinical use to avoid false positive and negative findings of
lung function disturbances and for epidemiological
studies to achieve more reliable figures of prevalences
of airways obstruction and restrictive impairment.
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